# Tjalf Ziemssen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tjalf-ziemssen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,290 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 65 |
| i10-index | 312 |
| Last Known Institution | University Hospital Carl Gustav Carus |
| OpenAlex ID | https://openalex.org/A5114375542 |
| ORCID iD | https://orcid.org/0000-0001-8799-8202 |
| Works | 721 |

## Researcher papers

- [Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension](https://scholariq.org/papers/effect-of-natalizumab-on-disease-progression-in-secondary-progressive-multiple/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Sphingolipid Metabolism and Signaling](https://scholariq.org/topics/sphingolipid-metabolism-and-signaling/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [University Hospital Carl Gustav Carus](https://scholariq.org/institutions/university-hospital-carl-gustav-carus/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.